Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells

Cancer Research

Volumn 59, Issue 1, 1999, Pages 213-218

  Chen, Taosheng ^a   Cho, Richard W ^a   Stork, Philip J S ^b   Weber, Michael J ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

BLOOD PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIC AMP; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HUMANS; INTERLEUKIN-6; MALE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0032952308     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Troppmair, J., Brader, J. T., App, H., Cai, H., Liptak, L., Szeberenyi, J., Cooper, G. M., and Rapp, U. R. Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol. Oncogene, 7: 1867-1873, 1992.
2. Miltenberger, R. J., Cortner, J., and Farnham, P. J. An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes. J. Biol. Chem., 268: 15674-15680, 1993.
3. Alessi, D. R., Saito, Y., Campbell, D. G., Cohen, P., Sithanandam, G., Rapp, U., Ashworth, A., Marshall, C. J., and Cowley, S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J., 13: 1610-1619, 1994.
4. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of N1H 3T3 cells. Cell. 77: 841-852, 1994.
5. Sale, E. M., Atkinson, P. G., and Sale, G. J. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J., 14: 674-684, 1995.
6. Alberola-lla, J., Forbush, K. A., Seger, R., Krebs, E. G., and Perlmutter, R. M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (Lond.), 373: 620-623, 1995.
7. Tsai, M., Chen, R. H., Tam, S. Y., Blenis, J., and Galli, S. J. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur. J. Immunol., 23: 3286-3291, 1993.
8. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., de Lanerolle, P., and Cheresh, D. A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol., 137: 481-492, 1997.
9. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J., and Sturgill, T. W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science (Washington DC), 262: 1065-1069, 1993.
10. Cook, S. J., and McCormick, F. Inhibition by cAMP of Ras-dependent activation of Raf. Science (Washington DC), 262: 1069-1072, 1993.
11. Hordijk, P. L., Verlaan, J., Jalink, K., van Corven, J., and Moolenaar, W. H. cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts. J. Biol. Chem., 269: 3534-3538, 1994.
12. Burgering, B. M., Pronk, G. J., van Weeren, C., Chardin, P., and Bos, J. L. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J., 12: 4211-4220, 1993.
13. Graves, L. M., Bornfeldt, K. E., Raines, E. W., Potts, B. C., Macdonald, S. G., Ross, R., and Krebs, E. G. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl Acad. Sci. USA, 90: 10300-10304, 1993.
14. Sevetson, B. R., Kong, X., and Lawrence, J. J. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA, 90: 10305-10309, 1993.
15. Vossler, M. R., Yao, H., York, R. D., Pan, M. G., Rim, C. S., and Stork, P. J. cAMP activates MAP kinase, and Elk-1 through a B-Raf-, and Rap1-dependent pathway. Cell, 89: 73-82, 1997.
16. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
17. Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J., and Johnson, G. L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science (Washington DC), 260: 315-319, 1993.
18. Vaillancourt, R. R., Gardner, A. M., and Johnson, G. L. B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol. Cell. Biol., 14: 6522-6530, 1994.
19. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thumher, M., Bartsch, G., and Klocker, H. Regulation of prostatic growth and function by peptide growth factors. Prostate, 28: 392-405, 1996.
20. Scher, H. I., Sarkis, A., Reuter, V., Cohen, D., Netto, G., Petrylak, D., Lianes, P., Fuks, Z., Mendelsohn, J., and Cordon-Cardo, C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms. Clin. Cancer Res., 1: 545-550, 1995.
21. Okamoto, M., Lee, C., and Oyasu, R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res., 57: 141-146, 1997.
22. di Sant'Agnese, P. A. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer (Phila.), 70: 254-268, 1992.
23. Shah, G. V., Noble, M. J., Austenfeld, M., Weigel, J., Deftos, L. J., and Mebust, W. K. Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells. Prostate, 21: 87-97, 1992.
24. Iwamura, M., di Sant'Agnese, P. A., Wu, G., Benning, C. M., Cockett, A. T., Deftos, L. J., and Abrahamsson, P. A. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res., 53: 1724-1726, 1993.
25. Bang, Y. J., Pirnia, F., Fang, W. G., Kang, W. K., Sartor, O., Whitesell, L., Ha, M. J., Tsokos, M., Sheahan, M. D., Nguyen, P., Niklinski, W. T., Myers, C. E., and Trepel, J. B. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc. Natl. Acad. Sci. USA, 91: 5330-5334, 1994.
26. 2+ transients. Endocrinology. 114: 596-602, 1994.
27. Hoosein, N. M., Logothetis, C. J., and Chung, L. W. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol., 149: 1209-1213, 1993.
28. Bonkhoff, H., Wernert, N., Dhom, G., and Remberger, K. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate, 19: 91-98, 1991.
29. Bonkhoff, H., and Remberger, K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate, 28: 98-106, 1996.
30. Horoszewicz, J. S., Leong, S. S., Chu, T. M., Wajsman, Z. L., Friedman, M., Papsidero, L., Kim, U., Chai, L. S., Kakati, S., Arya, S. K., and Sandberg. A. A. The LNCaP cell line: a new model for studies on human prostatic carcinoma. Prog. Clin. Biol. Res., 37: 115-132, 1980.
31. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54: 2577-2581, 1994.
32. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphalidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997
33. Reuter, C. W., Catling, A. D., and Weber, M. J. Immune complex kinase assays for mitogen-activated protein kinase and MEK. Methods Enzymol., 255: 245-256, 1995.
34. Bang, Y. J., Kim, S. J., Danielpour, D., O'Reilly, M. A., Kim, K. Y., Myers, C. E., and Trepel, J. B. Cyclic AMP induces transforming growth factor β2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. Proc. Natl. Acad. Sci. USA, 89: 3556-3560, 1992.
35. Post, G. R., and Brown, J. H. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J., 10: 741-749, 1996.
36. Pan, M. G., Wang, Y. H., Hirsch, D. D., LaBudda, K., and Stork, P. J. The Wnt-1 proto-oncogene regulates MAP kinase activation by multiple growth factors in PC12 cells. Oncogene, 11: 2005-2012, 1995.
37. York, R. D., Yao, H., Dillon, T., Ellig, C. L., Eckert, S. P., McCleskey, E. W., and Stork, P. S. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature (Lond.), 392: 622-626, 1998.
38. Ihara, S., Nakajima, K., Fukada, T., Hibi, M., Nagata, S., Hirano, T., and Fukui, Y. Dual control of neunte outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6. EMBO J., 16: 5345-5352, 1997.
39. Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marme, D., and Rapp, U. R. Protein kinase Ca activates RAF-1 by direct phosphorylation. Nature (Lond.), 364: 249-252, 1993.
40. El-Shemerly, M. Y., Besser, D., Nagasawa, M., and Nagamine, Y. 12-O-Tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of She in N1H3T3 cells. J. Biol. Chem., 272: 30599-30602, 1997.
41. Marais, R., Light, Y., Mason, C., Paterson, H., Olson, M. F., and Marshall, C. J. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science (Washington DC), 280: 109-112, 1998.
42. Messing, R. O., Stevens, A. M., Kiyasu, E., and Sneade, A. B. Nicotinic and muscarinic agonists stimulate rapid protein kinase C translocation in PC12 cells. J. Neurosci., 9: 507-512, 1989.
43. Rosen, L. B., Ginty, D. D., Weber, M. J., and Greenberg, M. E. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron, 12: 1207-1221, 1994.
44. Farnsworth, C. L., Freshney, N. W., Rosen, L. B., Ghosh, A., Greenberg, M. E., and Feig, L. A. Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature (Lond.), 376: 524-527, 1995.
45. Abrahamsson, P. A., Falkmer, S., Falt, K., and Grimelius, L. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker," Pathol. Res. Pract., 185: 373-380, 1989.
46. Abrahamsson, P. A. Neuroendocrine differentiation and hormone-refractory prostate cancer. Prostate Suppl., 6: 3-8, 1996.